Use of cefovecin in a UK population of cats attending first-opinion practices as recorded in electronic health records
Use of cefovecin in a UK population of cats attending first-opinion practices as recorded in electronic health records
复制标题
DOI：
10.1177/1098612x16656706
复制
发表时间：
2017-06-01
影响因子：
1.7
通讯作者：
Tasker, Severine
中科院分区：
文献类型：
--
作者：
Burke, Sara;Black, Vicki;Tasker, Severine
目的本研究的目的是使用电子健康记录来描述头孢维星的使用情况（Convenia;硕腾公司（英国），一种第三代长效注射用抗菌剂，在参加第一意见实践的英国猫群中，并将Convenia的使用与英国Convenia指南中描述的许可使用进行比较。方法数据以Excel数据库的形式从小动物兽医监督网络获得，从2012年9月1日至2013年9月23日（含），包含Convenia和/或头孢维星一词的磋商。根据接受治疗的身体系统、脓肿的确认或疑似、进行微生物评价的证据、给予的任何合并治疗以及是否有任何理由使用Convenia而不是替代抗菌药物对脓肿进行分类。结果共分析1148个条目。接受治疗的最常见身体系统为皮肤（553例，48.2%），其次为泌尿系统（n = 157; 13.7%）和呼吸系统（n = 112; 9.8%）。在193（16.8%）个条目中记录了微生物评价，最常引用的是可见化脓性物质（147 [12.8%]个条目）。在138个（12.0%）条目中给出了开Convenia而不是替代抗菌剂的原因;其中77个（55.8%）条目中引用最多的是无法口服猫。排除131个条目，没有身体系统或多个身体系统进行了描述，使用Convenia符合许可使用在英国的710（69.8%）的1017 entry.Conclusions和相关性大多数行政许可的用途，但是，大多数条目没有描述任何微生物学评价，或处方Convenia替代抗菌药物的原因。需要对公众和兽医专业进行进一步教育，以促进英国的抗菌管理。健康记录提供了一个有价值的工具，可以在当地和大规模监测抗菌药物等重要治疗药物的使用情况。与决策有关的信息应记录在个体动物健康记录中。
Objectives The objective was to use electronic health records to describe the use of cefovecin (Convenia; Zoetis UK), a third-generation long-acting injectable antimicrobial, in a UK population of cats attending first-opinion practices, and to compare the use of Convenia with the licensed uses described on the UK Convenia datasheet.Methods Data were obtained as an Excel database from the Small Animal Veterinary Surveillance Network for all feline consultations containing the word Convenia and/or cefovecin from 1 September 2012 to 23 September 2013 inclusive. Entries were classified according to body system treated, confirmation or suspicion of an abscess, evidence of microbiological evaluation being performed, any concurrent therapies given and whether any reason was given for use of Convenia over alternative antimicrobials. Data were exported to IBM SPSS Statistics and descriptive analysis performed.Results In total, 1148 entries were analysed. The most common body system treated was skin in 553 (48.2%) entries, then urinary (n = 157; 13.7%) and respiratory (n = 112; 9.8%). Microbiological evaluation was recorded in 193 (16.8%) entries, with visible purulent material most commonly cited (in 147 [12.8%] entries). A reason for prescribing Convenia over alternative antimicrobials was given in 138 (12.0%) entries; the most cited was an inability to orally medicate the cat in 77 (55.8%) of these entries. Excluding 131 entries where no body system or multiple body systems were described, the use of Convenia complied with a licensed use in the UK datasheet in 710 (69.8%) of 1017 entries.Conclusions and relevance Most administrations were licensed uses; however, most entries did not describe any microbiological evaluation, or a reason for prescribing Convenia over alternative antimicrobials. Further education of the public and the veterinary profession is needed to promote antimicrobial stewardship in the UK. Health records provide a valuable tool with which to monitor, both locally and at scale, the use of important therapeutics like antimicrobials. Information relevant to decision-making should be recorded in individual animal health records.